-
Most Popular
Search Results
240 results for cphd
Hottest Technology Stocks Now – SSNC NVDA AUO WWWW
Technology stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.5%.
Hottest Technology Stocks Now – TYL WBMD MDSO TQNT
Technology stocks rose broadly on Wall Street on Tuesday, with the sector seeing an overall increase of 1.0%.
7 Biotechnology Stocks to Buy Now
Seven biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
7 Biotechnology Stocks to Buy Now
This week, seven biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Biggest Movers in Technology Stocks Now – MITL CNQR WNS IACI
Technology stocks finished up broadly on Wall Street today, with the sector seeing an overall increase of 0.1%.
Biggest Movers in Technology Stocks Now – AUO EGOV QIHU UMC
Technology stocks rose 0.6% on Wall Street on Monday morning.
Biggest Movers in Technology Stocks Now – WBMD AMAT AZZ CSGP
Technology stocks finished down broadly on Wall Street on Tuesday, with the sector seeing an overall decline of 1.3%.
9 Healthy Biotech Buys
Baby boomers are getting older and in need of more and more treatments, thus the race for the next big blockbuster drug. Smaller biotechs are…
9 Recession-Proof Biotech Stocks To Cure What Ails You
Health care stocks stay firm during a down economy and investors should consider up-and-coming biotech stocks like Alexion, Alkermes, Biogen and Cepheid.
6 Biotechnology Stocks to Buy Now
The grades of six biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
6 Biotechnology Stocks to Sell Now
The overall ratings of six Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
Dynavax Technologies Corporation (DVAX) Steals Back Gains on Pending Heplisav Treatment
Dynavax Technologies (DVAX) is surging on news that the FDA is moving closer to approving Heplisav in time for its PDUFA date.
Dynavax Technologies Corporation (DVAX) Injected With 20%-Plus Gains
Dynavax Technologies Corporation (DVAX) stock is gaining back what it lost and then some after the pre-holiday-weekend rout. Is this a good time to buy?
How to Trade the Impending Obama Victory
President Obama is on his way to a victory in November and investors can take advantage with these 4 stocks that should perform well in…
24 Biotechnology Stocks to Buy Now
24 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
How to Play the Personalized Medicine Boom
Molecular diagnostics stocks may have some untapped upside.
25 Biotechnology Stocks to Buy Now
25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
5 Aggressive Growth Funds to Seize Now
With many investors on the fence about whether the market will move higher, here are some mutual funds that seek big growth in any market.
5 Mighty Small-Cap Stocks to Buy for 2014
Small-cap stocks are doing extremely well this year, and here are 5 small cap stocks to buy that should perform well for you in 2014.
Trade of the Day: PerkinElmer (PKI)
With our indicators returning to bullish mode, you should return to favoring bullish options trades over bearish ones.
5 Bargain Biotech Stocks to Buy
The biotech stocks on this list are speculative investments that could deliver huge returns.
5 Best Mutual Funds of the First Quarter
The first quarter’s bull market jolted stocks, and a number of mutual funds followed suit. Here’s a look at five of the best mutual funds,…
41 Biotechnology Stocks to Sell Now
The overall ratings of 41 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
4 – 10 of 240 results
